|
TW202041582A
|
|
Use of graphene-polymer composites to improve barrier resistance of polymers to liquid and gas permeants
|
|
AU2018362234A1
|
|
Polymer-based railroad tie having enhanced ballast interaction
|
|
AU2018261750A1
|
|
Type I and type III interferon fusion molecules and methods for use thereof
|
|
AU2018231120A1
|
|
Indole derivatives as efflux pump inhibitors
|
|
AU2018210990A1
|
|
Compositions for reducing sarcolipin expression and preventing and treating muscular dystrophy and cardiomyopathy and methods of use
|
|
TW201915053A
|
|
In situ bonding of carbon fibers and nanotubes to polymer matrices
|
|
AU2017321708A1
|
|
Methods and compositions for treating diseases and disorders of the nervous system
|
|
AU2017282659A1
|
|
Therapeutic compounds
|
|
AU2017246663A1
|
|
Multiplex nucleic acid assay methods capable of detecting closely related alleles, and reagents therefor
|
|
AU2017218424A1
|
|
Antimicrobial composition for inhibiting microbial organisms in allograft and the method thereof
|
|
AU2017218415A1
|
|
Novel anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections
|
|
AU2016244997A1
|
|
Extracts from plants of the Moringaceae family and methods of making
|
|
AU2015202526A1
|
|
Biocompatible polymers for medical devices
|
|
AU2014268199A1
|
|
Biocompatible Polymers for Medical Devices
|
|
AU2013203149A1
|
|
Lithium stimulation of cord blood stem cell proliferation and growth factor production
|
|
AU2012267929A1
|
|
Synthetic formulations and methods of manufacturing and using thereof
|
|
AU2010303170A1
|
|
Biocompatible polymers for medical devices
|
|
AU2010254820A1
|
|
Compositions and methods modulating MG29 for the treatment of diabetes
|
|
AU2009303332A1
|
|
Biocompatible polymers for medical devices
|
|
AU2009217337A1
|
|
Compositions and methods for treating ophthalmic diseases
|
